3Bone RC, Balk RA, Cerra FB, et aI.Definitions for sepsis and organ failure and guidelines for the use of innovalive therapies in sepsis [d] .Chest, 1992, 101 (6) :1644-1655.
4Bone RC. Sir Isaac Newton, sepsis, and CARS [J] .Crit-Care Med, 1996, 24:1125-1128.
5Colotta F, Dower SK, Sims JE, et al.The type II decoy receptor:a novel resulatory pathway for interleukin 1 [J] .Immunol Today, 1994, 15 (12):562-566.
6Mastsukawa A, Yoshimura T, Miymotok , et aI.Analysis of the inflammatory cytokine network among TNF alpha, IL-1 beta, IL-1 receptor antagonist, and IL-8 in LPS-induced rabbit arthritis [J] .Lab Invest, 1997, 76 (5) : 629-698.
7Lin YC, Brown K, Siebenlist U, et aI.Activation of NF-kappa B reguires proteolysis of the inhibitor I kappa B-alpha : signal-induced phosphorylation of I kappa alone does not release active NF-kappa B [J] .Proc Natl Acad Sci USA, 1995, 92 (2) :552-556
8Rahnn I, Mac Nee W.Role of transription factor in inflammatory lung disease [J] .Thorax, 1998, 53 (7):601-612.
9Boldt J, Brosch C, Lehmann A, et aI.Prophylactic use of pentoxifylline on inflammation in early cardiasurgery patients [J] .Ann Thorac Surg, 2001, 71 (5):1524-1529.
10Leeuwen H J, Bruggen J, AsbeckBS, et al.Effect of corticosteroids on ornuclear factor-kappa B activation and nemodynamics in late septic shock [J] .Crit Care Med, 2001, 29:1074-1077.
